Development of a Sustained-Release Oral Tablet of Tyrosine Kinase Inhibitor Imatinib Using Full Factorial Design. Dhaka University Journal of Pharmaceutical Sciences, [S. l.], v. 23, n. 2, p. 135–143, 2024. DOI: 10.3329/dujps.v23i2.78571. Disponível em: https://banglajol.info/index.php/JPharma/article/view/78571. Acesso em: 3 jul. 2026.